Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
Listen
19 Sep 2018
Transparency notifications BlackRock, Inc.
Read More
14 Sep 2018
Transparency notification BlackRock, Inc.
Read More
13 Sep 2018
Data Presented at EADV 2018 Further Demonstrate the Value of CIMZIA® (certolizumab pegol) and Bimekizumab, as UCB Commitment to Psoriasis and Immuno-Dermatology Grows
Read More
5 Sep 2018
Transparency notification BlackRock, Inc.
Read More
31 Aug 2018
Transparency notification BlackRock, Inc.
Read More
29 Aug 2018
Transparency notifications BlackRock, Inc.
Read More
24 Aug 2018
Transparency notification BlackRock, Inc.
Read More
16 Aug 2018
Transparency notification BlackRock, Inc.
Read More
12 Aug 2018
FDA Accepts New Drug Application (NDA) to review Midazolam Nasal Spray, an investigational product for the acute treatment of seizure clusters
Read More
10 Aug 2018
Transparency notification BlackRock, Inc.
Read More
Pagination
First page
Previous page
‹ Previous
…
Page
24
Page
25
Page
26
Page
27
Current page
28
Page
29
Page
30
Page
31
Page
32
…
Next page
Next ›
Last page
Subscribe to
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – español y portugués
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss